{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:53:52Z","timestamp":1773298432938,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.drugalcdep.2014.07.027","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T20:34:09Z","timestamp":1406925249000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: Cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum"],"prefix":"10.1016","volume":"143","author":[{"given":"U.","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Specka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Stratmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ochwadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10550490802019519","article-title":"Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions?","volume":"17","author":"Agrawal","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2011.06.003","article-title":"The cannabis withdrawal scale development: patterns and predictors of cannabis withdrawal and distress","volume":"119","author":"Allsop","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10550490701640985","article-title":"Withdrawal Symptoms do not predict relapse among subjects treated for cannabis dependence","volume":"16","author":"Arendt","year":"2007","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14737175.8.3.479","article-title":"Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence","volume":"8","author":"Benyamina","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1373\/clinchem.2012.195503","article-title":"Impact of prolonged cannabis smokers\u2018blood on per se drugged driving laws","volume":"59","author":"Bergamaschi","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","article-title":"Dose-related neurocognitive effects of marijuana use","volume":"59","author":"Bolla","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0029-1245173","article-title":"Cannabis use disorders. Part II: Psychiatric and somatic sequelae and comorbidities","volume":"78","author":"Bonnet","year":"2010","journal-title":"Fortschr. Neurol. Psychiat."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/alcalc\/agq081","article-title":"Comparison of two oral symptom-triggered pharmacological inpatient treatments of acute alcohol withdrawal: clomethiazole vs. clonazepam","volume":"46","author":"Bonnet","year":"2011","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0050","doi-asserted-by":"crossref","first-page":"e53127","DOI":"10.1371\/journal.pone.0053127","article-title":"Psychomotor function in chronic daily cannabis smokers during sustained abstinence","volume":"8","author":"Bosker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0055","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1360-0443.1999.94913114.x","article-title":"Marijuana withdrawal among adults seeking treatment for marijuana dependence","volume":"94","author":"Budney","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0060","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1176\/appi.ajp.161.11.1967","article-title":"Review of the validity and significance of cannabis withdrawal syndrome","volume":"161","author":"Budney","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms","volume":"86","author":"Budney","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0070","first-page":"28","article-title":"The clinical global impression scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgemont)"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0b013e31820c23fa","article-title":"An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions","volume":"5","author":"Crean","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007691-199312000-00013","article-title":"Relating blood concentrations of terahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage","volume":"15","author":"Cone","year":"1993","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/FQY06F8XKTQPM149","article-title":"The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine","volume":"128","author":"Dasgupta","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0090","series-title":"Internationale Klassifikation psychischer St\u00f6rungen. ICD-10 Kapitel V (F). Diagnostische Kriterien f\u00fcr Forschung und Praxis","author":"Dilling","year":"2004"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1037\/0022-006X.68.1.134","article-title":"The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties","volume":"68","author":"Fals-Stewart","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/dta.1401","article-title":"Considering gender in cannabinoid research: a step towards personalized treatment of marijuana addicts","volume":"5","author":"Fattore","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cpt1975174458","article-title":"Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man","volume":"17","author":"Feinberg","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1440-1614.1999.00565.x","article-title":"A double-blind, multicenter study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice","volume":"33","author":"Freed","year":"1999","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2011.11.007","article-title":"Diagnostic criteria for cannabis withdrawal syndrome","volume":"123","author":"Gorelick","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0125","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/FTD.0b013e318180c7c2","article-title":"Sensitivity and specifity of urinary cannabinoid detection with two immunoassays after controlled oral administration of delta-9-tetrahydrocannabinol to humans","volume":"30","author":"Grauwiler","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0130","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/j.1360-0443.2007.02009.x","article-title":"Developing limits for driving under cannabis","volume":"102","author":"Grotenhermen","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0135","author":"Gsellhofer","year":"1997","journal-title":"Deutsche Version des \u2018European Addiction Severity Index"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","volume":"197","author":"Haney","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-010-1888-6","article-title":"Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse","volume":"211","author":"Haney","year":"2010","journal-title":"Psychopharmacology"},{"issue":"Suppl. 416","key":"10.1016\/j.drugalcdep.2014.07.027_bib0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","volume":"107","author":"Haro","year":"2003","journal-title":"Acta Psychiatry Scand."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0155","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4088\/JCP.v69n0902","article-title":"Cannabis withdrawal in the United States: results from NESARC","volume":"69","author":"Hasin","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0160","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1-receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0165","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00115-008-2412-7","article-title":"Use of an outpatient treatment center for cannabis abuse","volume":"79","author":"H\u00f6lscher","year":"2008","journal-title":"Nervenarzt"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-008-1260-2","article-title":"Delta-9-Tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing 69mg THC","volume":"201","author":"Hunault","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00679783","article-title":"Terminal elimination plasma half-life of \u03941-tetrahydrocannabinol (\u03941-THC) in heavy users of marijuana","volume":"37","author":"Johansson","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0180","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jat\/33.8.469","article-title":"Implications of plasma \u03949-tetrahydrocannabinol, 11-Hydroxy-THC, and 11-nor-9-Carboxy-THC concentrations in chronic cannabis smokers","volume":"33","author":"Karschner","year":"2009","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00004850-200211000-00003","article-title":"Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials","volume":"17","author":"Khan","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0028-1108418","article-title":"Drug addiction among juveniles with special consideration of hashish smoking","volume":"95","author":"Kielholz","year":"1970","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0195","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1037\/1064-1297.8.4.483","article-title":"Abstinence symptoms during withdrawal from chronic marijuana use","volume":"8","author":"Kouri","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1521-0391.2014.12088.x","article-title":"Cannabis withdrawal in chronic, frequent smokers during sustained abstinence within a closed residental environment","volume":"23","author":"Lee","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.04.010","article-title":"Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers","volume":"111","author":"Levin","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0215","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","article-title":"Extended urinary \u03949-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure","volume":"105","author":"Lowe","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0220","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/npp.2012.14","article-title":"A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults","volume":"37","author":"Mason","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 3","key":"10.1016\/j.drugalcdep.2014.07.027_bib0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000057151","article-title":"Recent advantages in cannabinoid research","volume":"6","author":"Mechoulam","year":"1999","journal-title":"Forsch Komplementarmed."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0235","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/chi.0b013e31815cdd73","article-title":"Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study","volume":"47","author":"Milin","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0240","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/jat\/29.8.842","article-title":"THC can be detected in brain while absent in blood","volume":"29","author":"Mura","year":"2005","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.ftd.0000197091.07807.22","article-title":"Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use","volume":"28","author":"Musshoff","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0250","author":"Oberlandesgericht Brandenburg","year":"2007","journal-title":"Fahrverbot und THC\u2014Mindestgrenzwert. Az: 1 Ss (OWi) 291 B\/06. Beschluss vom 30.03.2007"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0255","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0260","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1024\/0939-5911.a000275","article-title":"Substanzkonsum und substanzbezogene St\u00f6rungen in Deutschland im Jahr 2012","volume":"59","author":"Pabst","year":"2013","journal-title":"Sucht"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.08.008","article-title":"Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients","volume":"106","author":"Preuss","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0270","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drugalcdep.2006.03.015","article-title":"Cognition and motor control as a function of \u0394-9-THC concentration in serum and oral fluid: limits of impairment","volume":"85","author":"Raemakers","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0285","series-title":"World Drug Report 2013","author":"United Nations Office on Drugs and Crime","year":"2013"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0290","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2007.06.010","article-title":"A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances","volume":"92","author":"Vandrey","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0295","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2011.01.003","article-title":"Sleep disturbance and the effects of extend-release zolpidem during cannabis withdrawal","volume":"117","author":"Vandrey","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2012.08.001","article-title":"The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users","volume":"128","author":"Vandrey","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0305","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1360-0443.1996.tb02251.x","article-title":"An evaluation of the history of a marijuana withdrawal syndrome in a large population","volume":"91","author":"Wiesbeck","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.07.027_bib0310","series-title":"Strukturiertes Klinisches Interview f\u00fcr DSM-IV. Achse II: Pers\u00f6nlichkeitsst\u00f6rungen.","author":"Wittchen","year":"1997"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614010163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614010163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T12:32:59Z","timestamp":1649853179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614010163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":58,"alternative-id":["S0376871614010163"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.07.027","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: Cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}